Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.7 (
adenine phosphoribosyltransferase
)
692
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This paper reports the detection of five inherited disorders of purine and one of pyrimidine metabolism using intact red blood cells (RBCs) and compares the findings with those from RBC lysate activity. Two different phosphate levels (1 and 18 mmol L-1 Pi) were used to evaluate endogenous PP-ribose-P levels and their generation by PP-ribose-P synthetase. The importance of this dual approach is demonstrated by the following evidence: (a) Six out of eight patients with no detectable hypoxanthine-guanine phosphoribosyltransferase (HGPRT) RBC lysate activity had up to 25% of normal activity in their intact RBCs. Two Lesch-Nyhan patients showed no detectable activity in intact or lysed RBCs. (b) RBC lysates from two heterozygotes for adenosine deaminase (ADA) deficiency also showed no detectable activity, but up to 60% of normal activity using intact RBCs. (c) The existence of an aberrant enzyme in a kindred with a superactive PP-ribose-P synthetase was evident from the fact that intact RBCs failed to respond normally to phosphate activation, despite normal HGPRT and
adenine phosphoribosyltransferase
(
APRT
) RBC lysate activity. (d) Raised endogenous PP-ribose-P levels in intact RBCs were demonstrable only in purine nucleoside phosphorylase (PNP) and HGPRT deficiency; levels were normal in APRT deficiency and hereditary oroticaciduria (
OPRT
/ODC) deficiency. The results indicate that diagnosis from RBC lysate activity alone may be misleading. Intact RBC studies clearly provide a better indication of the functional capacity of the enzyme in vivo. They also show a closer correlation with the clinical phenotype and allow further insight into the associated biochemical abnormalities in some cases.
...
PMID:Use of intact erythrocytes in the diagnosis of inherited purine and pyrimidine disorders. 244 57
Elevated levels of
APRT
activity are found in erythrocytes from most patients with a primary deficiency of HPRT. A twofold elevation of
APRT
activity has also been measured in hemolysate from one patient with a deficiency of both
OPRT
and ODC activity. In an attempt to further define the mechanisms responsible for these apparent alterations in
APRT
expression, we have studied the catalytic, immunochemical, and electrophoretic properties of
APRT
in erythrocytes from patients with these inborn errors of purine and pyrimidine metabolism. We have found that the elevated activity of
APRT
in HPRT-deficient erythrocytes results from an increased amount of a catalytically normal
APRT
protein. Immunochemical and electrophoretic studies that this
APRT
protein is structurally normal. One patient with a deficiency of
OPRT
-ODC demonstrated a fourfold increase in
APRT
protein; this enzyme was catalytically less efficient than
APRT
from normal controls.
...
PMID:Adenine phosphoribosyltransferase in patients with disorders of purine and pyrimidine metabolism. 706 17